Compare DECK & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DECK | FMS |
|---|---|---|
| Founded | 1973 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 14.2B |
| IPO Year | 1996 | N/A |
| Metric | DECK | FMS |
|---|---|---|
| Price | $100.74 | $22.71 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 23 | 2 |
| Target Price | ★ $122.20 | $30.00 |
| AVG Volume (30 Days) | ★ 1.8M | 572.5K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.04 | N/A |
| Revenue | ★ $4,985,612,000.00 | N/A |
| Revenue This Year | $11.16 | $1.41 |
| Revenue Next Year | $7.00 | $4.11 |
| P/E Ratio | $16.65 | ★ $15.62 |
| Revenue Growth | ★ 16.28 | N/A |
| 52 Week Low | $78.91 | $20.96 |
| 52 Week High | $131.58 | $30.46 |
| Indicator | DECK | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 32.43 | 42.71 |
| Support Level | $100.80 | $22.50 |
| Resistance Level | $104.62 | $24.08 |
| Average True Range (ATR) | 3.13 | 0.40 |
| MACD | -1.97 | -0.10 |
| Stochastic Oscillator | 2.53 | 30.25 |
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets a niche sandal brand called Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.